Your browser doesn't support javascript.
loading
Robust parametric modeling of Alzheimer's disease progression.
Mehdipour Ghazi, Mostafa; Nielsen, Mads; Pai, Akshay; Modat, Marc; Jorge Cardoso, M; Ourselin, Sébastien; Sørensen, Lauge.
Afiliação
  • Mehdipour Ghazi M; Biomediq A/S, Copenhagen, DK; Cerebriu A/S, Copenhagen, DK; Department of Computer Science, University of Copenhagen, Copenhagen, DK; Department of Medical Physics and Biomedical Engineering, University College London, London, UK. Electronic address: mehdipour@biomediq.com.
  • Nielsen M; Biomediq A/S, Copenhagen, DK; Cerebriu A/S, Copenhagen, DK; Department of Computer Science, University of Copenhagen, Copenhagen, DK.
  • Pai A; Biomediq A/S, Copenhagen, DK; Cerebriu A/S, Copenhagen, DK; Department of Computer Science, University of Copenhagen, Copenhagen, DK.
  • Modat M; Department of Medical Physics and Biomedical Engineering, University College London, London, UK; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
  • Jorge Cardoso M; Department of Medical Physics and Biomedical Engineering, University College London, London, UK; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
  • Ourselin S; Department of Medical Physics and Biomedical Engineering, University College London, London, UK; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
  • Sørensen L; Biomediq A/S, Copenhagen, DK; Cerebriu A/S, Copenhagen, DK; Department of Computer Science, University of Copenhagen, Copenhagen, DK.
Neuroimage ; 225: 117460, 2021 01 15.
Article em En | MEDLINE | ID: mdl-33075562
ABSTRACT
Quantitative characterization of disease progression using longitudinal data can provide long-term predictions for the pathological stages of individuals. This work studies the robust modeling of Alzheimer's disease progression using parametric methods. The proposed method linearly maps the individual's age to a disease progression score (DPS) and jointly fits constrained generalized logistic functions to the longitudinal dynamics of biomarkers as functions of the DPS using M-estimation. Robustness of the estimates is quantified using bootstrapping via Monte Carlo resampling, and the estimated inflection points of the fitted functions are used to temporally order the modeled biomarkers in the disease course. Kernel density estimation is applied to the obtained DPSs for clinical status classification using a Bayesian classifier. Different M-estimators and logistic functions, including a novel type proposed in this study, called modified Stannard, are evaluated on the data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) for robust modeling of volumetric magnetic resonance imaging (MRI) and positron emission tomography (PET) biomarkers, cerebrospinal fluid (CSF) measurements, as well as cognitive tests. The results show that the modified Stannard function fitted using the logistic loss achieves the best modeling performance with an average normalized mean absolute error (NMAE) of 0.991 across all biomarkers and bootstraps. Applied to the ADNI test set, this model achieves a multiclass area under the ROC curve (AUC) of 0.934 in clinical status classification. The obtained results for the proposed model outperform almost all state-of-the-art results in predicting biomarker values and classifying clinical status. Finally, the experiments show that the proposed model, trained using abundant ADNI data, generalizes well to data from the National Alzheimer's Coordinating Center (NACC) with an average NMAE of 1.182 and a multiclass AUC of 0.929.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2021 Tipo de documento: Article